{"version":"1.0","provider_name":"MELEMA Pharma GmbH","provider_url":"http:\/\/melemapharma.de\/en","author_name":"admin","author_url":"http:\/\/melemapharma.de\/en\/author\/admin\/","title":"About Melema - MELEMA Pharma GmbH","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"V4qiPGqe5l\"><a href=\"http:\/\/melemapharma.de\/en\/ueber-melema-immuntherapie-von-krebserkrankungen\/\">About Melema<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"http:\/\/melemapharma.de\/en\/ueber-melema-immuntherapie-von-krebserkrankungen\/embed\/#?secret=V4qiPGqe5l\" width=\"600\" height=\"338\" title=\"&#8220;About Melema&#8221; &#8212; MELEMA Pharma GmbH\" data-secret=\"V4qiPGqe5l\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=http:\/\/melemapharma.de\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Overview MELEMA Pharma is a private biopharmaceutical company that develops derivatives of natural substances for the immunotherapeutic treatment of cancer and for the activation of the immune system. The company was founded in 2013 and develops its substances in collaboration with partners from academia, hospitals, and industry. Before the products are brought into partnerships, the company brings its substances through preclinical and clinical development to proof of effectiveness in humans. The conclusion of possible partnerships is conceivable at every stage of development. The most advanced product of MELEMA is ME-503, a new active ingredient with cytolytic\/cytostatic and immunotherapeutic activity that triggers programmed cell death (apoptosis) of tumor cells and activates immune functions against cancer cells. &nbsp; History MELEMA Pharma GmbH [&hellip;]","thumbnail_url":"https:\/\/melemapharma.de\/wp-content\/uploads\/2014\/07\/2237-300-300x235.jpg"}